Unapproved and Potentially Unsafe Semaglutide Compounds Flood the Market Amidst Shortage The Food and Drug Administration (FDA) has recently raised concerns over the sale of modified glucagon-like peptide-1 (GLP-1) drugs, particularly semaglutide, prompting a warning to consumers. The United States has been grappling with a shortage of Ozempic and Wegovy, two vital drugs used to […]
